Kappelman, Michael D.

Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry

Brenner, E. J., Ungaro, R. C., Gearry, R. B., Kaplan, G. G., Kissous-Hunt, M., Lewis, J. D., Ng, S. C., Rahier, J.-F., Reinisch, W., Ruemmele, F. M., et al. (2020) · Gastroenterology

COVID-19 Clinical Research StudiesInflammatory Bowel Disease

Cited by 674

Evaluation of the Patient-Reported Outcomes Measurement Information System in a Large Cohort of Patients With Inflammatory Bowel Diseases

Kappelman, M. D., Long, M. D., Martin, C., DeWalt, D. A., Kinneer, P. M., Chen, W., Lewis, J. D., & Sandler, R. S. (2014) · Clinical Gastroenterology and Hepatology

Inflammatory Bowel DiseaseHealth Systems, Economic Evaluations, Quality of Life

Cited by 178

Isotretinoin use and the risk of inflammatory bowel disease: a case-control study

Crockett, S. D., Porter, C. Q., Martin, C. F., Sandler, R. S., & Kappelman, M. D. (2010) · American Journal of Gastroenterology

Inflammatory Bowel DiseaseAcne and Rosacea Treatments and Effects

Cited by 161

The burden of comedication among patients with inflammatory bowel disease

Buckley, J. P., Kappelman, M. D., Allen, J. K., Van Meter, S. A., & Cook, S. F. (2013) · Inflammatory Bowel Diseases

Pharmaceutical Practices and Patient OutcomesInflammatory Bowel Disease

Cited by 59

Risk factors for depression in the elderly inflammatory bowel disease population

Long, M. D., Kappelman, M. D., Martin, C. F., Chen, W., Anton, K., & Sandler, R. S. (2014) · Journal of Crohn's and Colitis

Inflammatory Bowel DiseaseTryptophan and brain disorders

Cited by 53